A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
The aerosol platform promises broader protection against SARS-CoV-2, and is currently being trialed as a booster.
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
Living machines made from drug-carrying bacteria target tumors to improve the effectiveness and safety of chemotherapies.
A part of the SARS-CoV-2 spike protein could prove to be its Achilles’ heel.
Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.
Using atomically-thin 2D films, researchers have developed a nano-scale random number generator with enhanced long-term stability and reduced power consumption.
Dendritic cell vaccines offer a unique opportunity in biomedicine, and limitations in efficacy can now potentially be overcome using graphene oxide nanosheets.
COVID-19 is unlikely to be the last coronavirus to spill over to humans. Scientists are working to make a universal vaccine to combat future outbreaks.
Genomic editing tools can reverse disease causing mutations to provide cures — once we can conquer the remaining barriers.